Fulminant hepatic failure after high-dose cytosine arabinoside and mitoxantrone treatment for relapse of acute myelogenous leukaemia

Eur J Haematol. 1992 Oct;49(4):221-3. doi: 10.1111/j.1600-0609.1992.tb00052.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cytarabine / administration & dosage
  • Cytarabine / adverse effects*
  • Daunorubicin / administration & dosage
  • Female
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Liver / pathology
  • Liver Failure, Acute / chemically induced*
  • Liver Failure, Acute / pathology
  • Mitoxantrone / administration & dosage
  • Mitoxantrone / adverse effects*
  • Necrosis
  • Recurrence
  • Thioguanine / administration & dosage

Substances

  • Cytarabine
  • Mitoxantrone
  • Thioguanine
  • Daunorubicin

Supplementary concepts

  • DAT protocol 1